Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Actelion HQ Switzerland

Actelion gets US green light for new PAH drug Opsumit

Approval will help reduce impact of generic competition for Tracleer

- PMLiVE

This month in 1884: How ‘friable’ pills changed medicine delivery

This month in 1884: Dr William Upjohn files key structural patent for revolutionary pill design

- PMLiVE

Mylan hires Jacek Glinka as European head

He will join the firm from Poland’s Polpharma

- PMLiVE

Does your medical education drive change in clinical practice?

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Lucid Group Communications Limited

- PMLiVE

Astellas wins NICE backing for Xtandi in prostate cancer

England’s health guidance body says drug can be used in advanced cases of the disease

- PMLiVE

Amarin slides as FDA panel votes against fish oil therapy

Advisory committee wants more data on Vascepa

- PMLiVE

Budget deal brings FDA back to life

US Congress agreement allows employees at the regulator to return to work

Orphan drugs: the early access regulatory environment

Despite considerable variation to the rules for unlicensed orphan drugs, there are some clear first steps for a global access programme

- PMLiVE

Pan appoints new associate director and head of art

Jan Reiss joins and Rafe Burchell is promoted

- PMLiVE

Divining your future in healthcare

To soar in the face of change, leaders need the ability to engage in an ongoing process of strategic creativity

- PMLiVE

Union pressure delays Teva’s Israeli layoffs

Workforce cuts put on hold

Sanofi reception

Sanofi and Regeneron’s cholesterol antibody aces phase III trial

Results confirm companies' lead over Amgen, Pfzer, Roche and Novartis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links